Submitted by Anonymous (not verified) on 20 September 2024 - 11:00
Human medicines European public assessment report (EPAR): Hympavzi, Marstacimab, Status: Opinion
Source:
Human medicines European public assessment report (EPAR): Hympavzi, Marstacimab, Status: Opinion